trending Market Intelligence /marketintelligence/en/news-insights/trending/bghirsocwfkv0zfh9g_ntw2 content esgSubNav
In This List

Tonix Pharmaceuticals director steps down; replacement named

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Tonix Pharmaceuticals director steps down; replacement named

Tonix Pharmaceuticals Holding Corp. said Stuart Davidson stepped down from the company's board.

The company has added David Grange to replace Davidson, who had been a board member since 2011.

Grange is currently with Pharm-Olam International Ltd. as CEO.